Comment on "Expression of Helios in peripherally induced Foxp3 + regulatory T cells"

Journal of Immunology

Volumn 189, Issue 2, 2012, Pages 500-

  Elkord, Eyad ^a,b  

^a UNIVERSITY OF SALFORD   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR HELIOS; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

AUTOIMMUNE DISEASE; CANCER PATIENT; EFFECTOR CELL; HUMAN; LETTER; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC INFILTRATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; TUMOR ASSOCIATED LEUKOCYTE;

ANIMALS; FORKHEAD TRANSCRIPTION FACTORS; IKAROS TRANSCRIPTION FACTOR;

EID: 84863612566     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1290033     Document Type: Letter

References (11)

1. Thornton, A. M., P. E. Korty, D. Q. Tran, E. A. Wohlfert, P. E. Murray, Y. Belkaid, and E. M. Shevach. 2010. Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells. J. Immunol. 184: 3433-3441.
2. Akimova, T., U. H. Beier, L. Wang, M. H. Levine, and W. W. Hancock. 2011. Helios expression is a marker of T cell activation and proliferation. PLoS ONE 6: e24226.
3. Verhagen, J., and D. C. Wraith. 2010. Comment on "Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells". J. Immunol. 185: 7129.
4. Zabransky, D. J., C. J. Nirschl, N. M. Durham, B. V. Park, C. M. Ceccato, T. C. Bruno, A. J. Tam, D. Getnet, and C. G. Drake. 2012. Phenotypic and functional properties of Helios+ regulatory T cells. PLoS ONE 7: e34547.
5. Gottschalk, R. A., E. Corse, and J. P. Allison. 2012. Expression of Helios in peripherally induced Foxp3+ regulatory T cells. J. Immunol. 188: 976-980.
6. Bilate, A. M., and J. J. Lafaille. 2012. Induced CD4+Foxp3+ regulatory T cells in immune tolerance. Annu. Rev. Immunol. 30: 733-758.
7. Elkord, E., S. Sharma, D. J. Burt, and R. E. Hawkins. 2011. Expanded subpopulation of FoxP3+ T regulatory cells in renal cell carcinoma co-express Helios, indicating they could be derived from natural but not induced Tregs. Clin. Immunol. 140: 218-222.
8. Wainwright, D. A., S. Sengupta, Y. Han, and M. S. Lesniak. 2011. Thymusderived rather than tumor-induced regulatory T cells predominate in brain tumors. Neuro-oncol. 13: 1308-1323.
9. Wang, C., J. H. Lee, and C. H. Kim. 2012. Optimal population of FoxP3+ T cells in tumors requires an antigen priming-dependent trafficking receptor switch. PLoS ONE 7: e30793.
10. Kim, Y. C., R. Bhairavabhotla, J. Yoon, A. Golding, A. M. Thornton, D. Q. Tran, and E. M. Shevach. 2012. Oligodeoxynucleotides stabilize Helios-expressing Foxp3+ human T regulatory cells during in vitro expansion. Blood 119: 2810-2818.
11. Kryczek, I., R. Liu, G. Wang, K. Wu, X. Shu, W. Szeliga, L. Vatan, E. Finlayson, E. Huang, D. Simeone, et al. 2009. FOXP3 defines regulatory T cells in human tumor and autoimmune disease. Cancer Res. 69: 3995-4000.